These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8932338)

  • 1. Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ.
    Munn KE; Walker RA; Menasce L; Varley JM
    Br J Cancer; 1996 Nov; 74(10):1578-85. PubMed ID: 8932338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
    Chitemerere M; Andersen TI; Holm R; Karlsen F; Børresen AL; Nesland JM
    Breast Cancer Res Treat; 1996; 41(2):103-9. PubMed ID: 8944328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
    Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E
    Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breast.
    Munn KE; Walker RA; Menasce L; Varley JM
    Br J Cancer; 1996 Mar; 73(5):636-9. PubMed ID: 8605099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
    Murphy DS; Hoare SF; Going JJ; Mallon EE; George WD; Kaye SB; Brown R; Black DM; Keith WN
    J Natl Cancer Inst; 1995 Nov; 87(22):1694-704. PubMed ID: 7473818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.
    Buerger H; Simon R; Schäfer KL; Diallo R; Littmann R; Poremba C; van Diest PJ; Dockhorn-Dworniczak B; Böcker W
    Mol Pathol; 2000 Jun; 53(3):118-21. PubMed ID: 10897329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors.
    Plummer SJ; Paris MJ; Myles J; Tubbs R; Crowe J; Casey G
    Genes Chromosomes Cancer; 1997 Dec; 20(4):354-62. PubMed ID: 9408751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections.
    Chen T; Dhingra K; Sahin A; Sneige N; Hortobagyi G; Aldaz CM
    Breast Cancer Res Treat; 1996; 39(2):177-85. PubMed ID: 8872326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.
    Done SJ; Arneson NC; Ozçelik H; Redston M; Andrulis IL
    Cancer Res; 1998 Feb; 58(4):785-9. PubMed ID: 9485035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast.
    Done SJ; Eskandarian S; Bull S; Redston M; Andrulis IL
    J Natl Cancer Inst; 2001 May; 93(9):700-4. PubMed ID: 11333292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
    Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
    Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In microdissected ductal carcinoma in situ, HER-2/neu amplification, but not p53 mutation, is associated with high nuclear grade and comedo histology.
    Ho GH; Calvano JE; Bisogna M; Borgen PI; Rosen PP; Tan LK; Van Zee KJ
    Cancer; 2000 Dec; 89(11):2153-60. PubMed ID: 11147584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis.
    Rane SU; Mirza H; Grigoriadis A; Pinder SE
    Breast Cancer Res Treat; 2015 Aug; 153(1):101-21. PubMed ID: 26255059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.
    Buerger H; Otterbach F; Simon R; Poremba C; Diallo R; Decker T; Riethdorf L; Brinkschmidt C; Dockhorn-Dworniczak B; Boecker W
    J Pathol; 1999 Mar; 187(4):396-402. PubMed ID: 10398097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.
    Asch HL; Winston JS; Edge SB; Stomper PC; Asch BB
    Breast Cancer Res Treat; 1999 May; 55(2):179-88. PubMed ID: 10481945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics.
    Visscher DW; Wallis TL; Crissman JD
    Cancer; 1996 Jan; 77(2):315-20. PubMed ID: 8625240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathologic analysis of chromosome aneuploidy in ductal carcinoma in situ.
    Visscher D; Jimenez RE; Grayson M; Mendelin J; Wallis T
    Hum Pathol; 2000 Feb; 31(2):201-7. PubMed ID: 10685634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity and microsatellite instability in ductal carcinoma in situ of the breast.
    Ando Y; Iwase H; Ichihara S; Toyoshima S; Nakamura T; Yamashita H; Toyama T; Omoto Y; Karamatsu S; Mitsuyama S; Fujii Y; Kobayashi S
    Cancer Lett; 2000 Aug; 156(2):207-14. PubMed ID: 10880771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast.
    Radford DM; Fair K; Thompson AM; Ritter JH; Holt M; Steinbrueck T; Wallace M; Wells SA; Donis-Keller HR
    Cancer Res; 1993 Jul; 53(13):2947-9. PubMed ID: 8391383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.